RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
In vivo evaluation of the LSD1 inhibitor SP-2577 against Ewing sarcoma and rhabdomyosarcoma preclinincal models
A report from the Pediatric Preclinical Testing Consortium (PPTC)
Houghton, P. J., Erickson, S. W., Teicher, B., Smith, M. A., Han, R., & Kurmasheva, R. (2019). In vivo evaluation of the LSD1 inhibitor SP-2577 against Ewing sarcoma and rhabdomyosarcoma preclinincal models: A report from the Pediatric Preclinical Testing Consortium (PPTC). Cancer Research, 79(13). https://doi.org/10.1158/1538-7445.SABCS18-3848